309 related articles for article (PubMed ID: 2201096)
21. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
22. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
Malmström PU
Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
[TBL] [Abstract][Full Text] [Related]
24. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Miyakawa A; Tachibana M; Tazaki H
Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
[TBL] [Abstract][Full Text] [Related]
26. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
Hedley DW; Rugg CA; Ng AB; Taylor IW
Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
[TBL] [Abstract][Full Text] [Related]
27. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
Hedley DW; Friedlander ML; Taylor IW
Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
29. [Flow cytometry in the evaluation of the prognosis and course of malignant soft-tissue tumors].
Zubrikhina GN; Ol'khovskaia IG
Arkh Patol; 1990; 52(9):29-33. PubMed ID: 2270977
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of cytofluorometry in bladder tumors].
Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
Bittard H; Lamy B; Billery C
J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
[TBL] [Abstract][Full Text] [Related]
35. Prediction of relapse in patients with breast cancer by DNA cytometry.
Machado-Santelli GM; Mori L; Pereira CA
Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156
[TBL] [Abstract][Full Text] [Related]
36. [Flow cytometric DNA analysis of malignant potential in colorectal cancer].
Ando Y; Tsuchiya A; Oki S; Sato H; Yoshida T; Kimijima I; Abe R
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():112-7. PubMed ID: 8678552
[TBL] [Abstract][Full Text] [Related]
37. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
39. DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices.
Bawani M; Tibrewala S; Copur S; Harris D; Gilman-Sachs A
Am J Gastroenterol; 1991 Feb; 86(2):191-5. PubMed ID: 1992633
[TBL] [Abstract][Full Text] [Related]
40. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]